FDA warns doctors against 'vaginal rejuvenation' treatments, says procedures pose serious risks

The Food and Drug Administration on Tuesday issued a safety notice to physicians and patients, as well as letters to seven manufacturers about "inappropriate marketing" of their devices for vaginal rejuvenation procedures.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.